Got to remember EU market is 1 billion growing 3% annual, hit this one out of the park then we can focus on FDA. How many times have Companies approached it this way, countless.
big derisk now as we know what to expect. Big re-rate for company coming when market catches on that we are at 17 mill EV for a company starting PHASE 3 trials
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-13
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28320 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 22452 | 2 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable